Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1474-4465